Medical Oncology

Papers
(The TQCC of Medical Oncology is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Steps in metastasis: an updated review135
Cancer treatment during COVID-19 pandemic52
Exosomes and cancer: from molecular mechanisms to clinical applications48
An updated review of epidemiology, risk factors, and management of male breast cancer34
Combating TKI resistance in CML by inhibiting the PI3K/Akt/mTOR pathway in combination with TKIs: a review34
Artificial Intelligence in radiotherapy: state of the art and future directions32
Strategies for having a more effective and less toxic CAR T-cell therapy for acute lymphoblastic leukemia30
Myths and facts about artificial intelligence: why machine- and deep-learning will not replace interventional radiologists30
Cancer and COVID-19: Why are cancer patients more susceptible to COVID-19?28
Neuroendocrine breast carcinoma: a rare but challenging entity25
MicroRNAs and target molecules in bladder cancer24
COVID-19 and cancer care: what do international guidelines say?24
The anti-angiogenic agent lenvatinib induces tumor vessel normalization and enhances radiosensitivity in hepatocellular tumors24
Targeting of oncogenic signaling pathways by berberine for treatment of colorectal cancer23
Circular RNAs and their participation in stemness of cancer23
Luteolin and cancer metastasis suppression: focus on the role of epithelial to mesenchymal transition20
Bexarotene inhibits cell proliferation by inducing oxidative stress, DNA damage and apoptosis via PPARγ/ NF-κB signaling pathway in C6 glioma cells19
Comparative bioinformatical analysis of pancreatic head cancer and pancreatic body/tail cancer19
Associated analysis of PER1/TUBB2B with endometrial cancer development caused by circadian rhythm disorders19
Cancer stem cells in colorectal cancer and the association with chemotherapy resistance19
Acute myeloid leukemia sensitivity to metabolic inhibitors: glycolysis showed to be a better therapeutic target18
Wee1 kinase inhibitor AZD1775 potentiates CD8+ T cell-dependent antitumour activity via dendritic cell activation following a single high dose of irradiation18
Identification of hub genes associated with obesity-induced hepatocellular carcinoma risk based on integrated bioinformatics analysis18
De novo neuroendocrine transdifferentiation in primary prostate cancer–a phenotype associated with advanced clinico-pathologic features and aggressive outcome17
Cinnamaldehyde induces endogenous apoptosis of the prostate cancer-associated fibroblasts via interfering the Glutathione-associated mitochondria function17
Integration of gene expression data identifies key genes and pathways in colorectal cancer16
Vaccination of cancer patients against COVID-19: towards the end of a dilemma16
PSMA: a game changer in the diagnosis and treatment of advanced prostate cancer15
Cancer induced bone pain: current management and future perspectives15
Melittin, a honeybee venom derived peptide for the treatment of chemotherapy-induced peripheral neuropathy15
PARP1-modulated chromatin remodeling is a new target for cancer treatment15
Molecular targets and therapeutics in chemoresistance of triple-negative breast cancer15
Estimating copy number using next-generation sequencing to determine ERBB2 amplification status14
Combination of resveratrol and BIBR1532 inhibits proliferation of colon cancer cells by repressing expression of LncRNAs14
Treating MCF7 breast cancer cell with proteasome inhibitor Bortezomib restores apoptotic factors and sensitizes cell to Docetaxel14
Cancer stem cell characteristics and their potential as therapeutic targets14
The role of inflammatory indices in the outcome of COVID-19 cancer patients14
Organoid culture system for patient-derived lung metastatic osteosarcoma13
Suppression of PTTG1 inhibits cell angiogenesis, migration and invasion in glioma cells13
Resveratrol effects in oral cancer cells: a comprehensive review13
Knockdown of lncRNA HIF1A-AS2 increases drug sensitivity of SCLC cells in association with autophagy13
CDK9 inhibitors in multiple myeloma: a review of progress and perspectives13
Quality of life, symptoms and dietary habits in oncology outpatients with malnutrition: A cross-sectional study13
High KIFC1 expression is associated with poor prognosis in prostate cancer13
Apigenin increases radiosensitivity of glioma stem cells by attenuating HIF-1α-mediated glycolysis12
Innovation in cancer therapeutics and regulatory perspectives12
N-Myc promotes angiogenesis and therapeutic resistance of prostate cancer by TEM812
Impact of preexisting antinuclear antibodies on combined immunotherapy and chemotherapy in advanced non-small cell lung cancer patients12
Docetaxel plus cisplatin in recurrent and/or metastatic non-squamous-cell head and neck cancer: a multicenter phase II trial12
Bioymifi, a novel mimetic of TNF-related apoptosis-induced ligand (TRAIL), stimulates eryptosis12
Iron overload is related to muscle wasting in patients with cachexia of gastric cancer: using quantitative proteome analysis12
Melittin inhibits the expression of key genes involved in tumor microenvironment formation by suppressing HIF-1α signaling in breast cancer cells12
Multidisciplinary total eradication therapy (TET) in men with newly diagnosed oligometastatic prostate cancer12
SBRT in non-spine bone metastases: a literature review12
Head and neck radiotherapy amid the COVID-19 pandemic: practice recommendations of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)11
Short-term effects of a Paleolithic lifestyle intervention in breast cancer patients undergoing radiotherapy: a pilot and feasibility study11
Lipid droplet evolution gives insight into polyaneuploid cancer cell lipid droplet functions11
Effects of SLC31A1 and ATP7B polymorphisms on platinum resistance in patients with esophageal squamous cell carcinoma receiving neoadjuvant chemoradiotherapy11
Influence of ballroom dancing on fatigue, body image, self-efficacy, and endurance of cancer patients and their partners11
COVID-19 pandemic: a new cause of unplanned interruption of radiotherapy in breast cancer patients11
Live cell molecular analysis of primary prostate cancer organoids identifies persistent androgen receptor signaling11
Prevalence of mutations in BRCA and MMR genes in patients affected with hereditary endometrial cancer11
Synergistic effects of multiple myeloma cells and tumor-associated macrophages on vascular endothelial cells in vitro11
The CXCL12/CXCR7 signalling axis promotes proliferation and metastasis in cervical cancer11
nab-Paclitaxel and cisplatin followed by cisplatin and radiation (Arm 1) and nab-paclitaxel followed by cetuximab and radiation (Arm 2) for locally advanced head and neck squamous-cell carcinoma: a mu10
Suppressed PLIN3 frequently occurs in prostate cancer, promoting docetaxel resistance via intensified autophagy, an event reversed by chloroquine10
MYH9 suppresses melanoma tumorigenesis, metastasis and regulates tumor microenvironment10
Regulatory mechanisms of heme regulatory protein BACH1: a potential therapeutic target for cancer10
Preliminary results in unresectable cholangiocarcinoma treated by CT percutaneous irreversible electroporation: feasibility, safety and efficacy10
Elevated LINC01550 induces the apoptosis and cell cycle arrest of melanoma10
Isolation and characterization of a novel GRP78-specific single-chain variable fragment (scFv) using ribosome display method10
The effect of metformin when combined with neoadjuvant chemotherapy in breast cancer patients10
The prostate-specific membrane antigen (PSMA)-targeted radiotracer 18F-DCFPyL detects tumor neovasculature in metastatic, advanced, radioiodine-refractory, differentiated thyroid cancer10
Combined crizotinib and endocrine drugs inhibit proliferation, migration, and colony formation of breast cancer cells via downregulation of MET and estrogen receptor10
0.024397850036621